TMCI

Treace Medical Concepts Stock Analysis

AI Rating

Low
  • Quality2/10
  • Growth↓ 1/10
  • Value↓ 3/10
Treace Medical Concepts sales and earnings growth
TMCI Growth
Low
  • Revenue Y/Y↓ 1.59%
  • EPS Y/Y↓ -3.33%
  • FCF Y/Y↑ 39.53%
Treace Medical Concepts gross and profit margin trends
TMCI Profitability
Fair
  • Gross margin ↑ 79.80%
  • EPS margin↓ -27.70%
  • ROIC 5Y↓ -22.06%
Treace Medical Concepts net debt vs free cash flow
TMCI Risk
Great
  • Debt / Equity↓ 0.8
  • Debt / FCF↓ 2.0
  • Interest coverage↓ -10.1

Treace Medical Concepts stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Medical Devices stocks ↗